Clinical observation of Liu's infantile tuina therapy for allergic rhinitis

刘氏小儿推拿治疗过敏性鼻炎的临床疗效观察（英文）

Objective： To discuss the clinical efficacy of Liu＇s infantile tuina therapy in treating kid＇s allergic rhinitis （AR）. Methods： Sixty eligible AR kids were randomized into a tuina group and a Western medication group by their visiting sequence, 30 cases in each group. The tuina group was intervened by Liu＇s infantile tuina therapy, once daily, 5 times as a treatment course, with a 2-day interval after a course; the control group was by orally taking Loratadine. The therapeutic efficacies were compared and analyzed after treatment for 4 successive weeks. Results： After treatment, the symptoms such as itchy nose, sneezing, runny nose, and stuffy nose were significantly improved in both groups （P〈0.05）, and the improvements in the tuina group were more remarkable than those in the Western medication group （P〈0.05）. The total effective rate was 90.0% in the tuina group versus 73.3% in the Western medication group, and the difference was statistically significant （P〈0.05）. Conclusion： Liu＇s infantile tuina therapy can produce a better therapeutic efficacy in treating AR kids compared to oral administration of Loratadine.

目的:探讨刘氏小儿推拿疗法治疗儿童过敏性鼻炎(allergic rhinitis,AR)的临床疗效。方法:选取符合纳入标准的AR患儿60例,根据就诊顺序随机分为推拿组和西药组,每组30例。推拿组予以刘氏小儿推拿治疗,每日治疗1次,治疗5次为1个疗程,疗程后休息2 d;对照组予以口服氯雷他定治疗。连续治疗4个星期后对比分析两组治疗效果。结果:治疗后两组患者鼻痒、喷嚏、流涕、鼻塞等症状均得到改善,与本组治疗前相比较,差异均有统计学意义(P<0.05),且推拿组患儿改善情况优于西药组(P<0.05)。推拿组总有效率90.0%,西药组总有效率73.3%,两组总有效率差异有统计学意义(P<0.05)。结论:刘氏小儿推拿治疗AR患儿的疗效优于口服氯雷他定。